Oxyphenisatine

From WikiMD's WELLNESSPEDIA

(Redirected from Veripaque)


File:Oxyphenisatin synthesis.svg
Chemical synthesis of Oxyphenisatine

Oxyphenisatine is a laxative that was previously used in the treatment of constipation. It is a derivative of phenolphthalein and acts as a stimulant laxative, promoting bowel movements by irritating the lining of the intestine.

Chemical Structure and Synthesis[edit]

Oxyphenisatine is chemically related to phenolphthalein, a compound historically used as a laxative. The chemical synthesis of oxyphenisatine involves the reaction of phenolphthalein with hydrazine to form the hydrazone, which is then oxidized to produce the final compound. The synthesis process is illustrated in the adjacent diagram.

Mechanism of Action[edit]

Oxyphenisatine works by stimulating the enteric nervous system, which increases peristalsis in the colon. This action results in the accelerated movement of fecal matter through the bowel, leading to defecation. The compound also causes the secretion of water and electrolytes into the intestinal lumen, softening the stool and making it easier to pass.

Clinical Use[edit]

Oxyphenisatine was used primarily for the relief of constipation. It was available in various formulations, including tablets and suppositories. However, due to concerns about its safety profile, particularly its potential to cause hepatotoxicity, its use has been largely discontinued in favor of safer alternatives.

Safety and Side Effects[edit]

The use of oxyphenisatine has been associated with several adverse effects. The most significant of these is liver damage, which can occur with prolonged use. Other side effects include abdominal cramping, diarrhea, and electrolyte imbalance. Due to these risks, oxyphenisatine is no longer recommended for use as a laxative.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.